J.Molner AS (OTSE:MOLNR) GF Value Rank: 10 (As of Sep. 03, 2026) — 100% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OTSE:MOLNR J.Molner AS OTSE:MOLNR
41 GF Score
Price €18.00
GF Value €19.65
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is J.Molner AS GF Value Rank?

J.Molner AS OTSE:MOLNR 41 GF Value Rank is 10 as of Sep. 03, 2026, which is 100% above its 10-year median of 5.00. GuruFocus rates OTSE:MOLNR with a GF Score™ of 41/100 and a GF Value™ of €19.65 (Fairly Valued). The stock has 7 warning signs investors should review.

J.Molner AS has the GF Value Rank of 10.

GF Value Rank evaluates the exclusive GuruFocus valuation and performance of a stock, rated on a scale from 1 to 10. It is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

A higher score indicates a stock with a relatively low valuation and substantial potential for outperformance. Conversely, a lower score often reflects stocks that are either highly overvalued or deeply undervalued, both of which tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

J.Molner AS GF Value Rank Related Terms

OTSE:MOLNR vs ZTS, UTHR, VTRS: GF Value Rank Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, J.Molner AS's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

J.Molner AS GF Value Rank vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, J.Molner AS's GF Value Rank distribution charts can be found below:

* The bar in red indicates where J.Molner AS's GF Value Rank falls into.


OTSE:MOLNR
41GF Score
J.Molner AS OTSE:MOLNR
GF Value Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Value Rank →
What does a GF Value Rank of 10 mean?
J.Molner AS (OTSE:MOLNR) has a GF Value Rank of 10 as of Sep. 03, 2026. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on J.Molner AS and its competitors. This is 100% above median its historical median of 5.00. Over the past decade, J.Molner AS's GF Value Rank has ranged from 3.00 to 10.00.
Is J.Molner AS's GF Value Rank too high?
J.Molner AS's current GF Value Rank of 10 is 100% above median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 10.00. Overall, J.Molner AS has a GF Score™ of 41/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does J.Molner AS's GF Value Rank compare to ZTS and UTHR?
J.Molner AS's GF Value Rank of 10 can be compared against companies in the Drug Manufacturers industry. Historically, J.Molner AS's own GF Value Rank has ranged from 3.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Value Rank for a Drug Manufacturers company?
A good GF Value Rank depends on the Drug Manufacturers industry context. However, GF Value Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Value Rank mean?
A high GF Value Rank can signal that a stock is expensive relative to its fundamentals. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on J.Molner AS and its competitors. J.Molner AS's current GF Value Rank is 10, which is 100% above median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is J.Molner AS stock overvalued right now?
Based on GuruFocus' analysis, J.Molner AS (OTSE:MOLNR) is currently considered Fairly Valued. The stock's GF Value™ is €19.65, compared to a current price of €18.00 — trading 8.4% below its estimated fair value. The current GF Value Rank is 10, which is 100% above median its 10-year median of 5.00. J.Molner AS's overall GF Score™ is 41/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Value Rank calculated?
GF Value Rank is calculated from a company's financial statements. For J.Molner AS (OTSE:MOLNR), the current GF Value Rank is 10 as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is J.Molner AS (OTSE:MOLNR) Overvalued in 2026?

Based on GuruFocus' analysis, J.Molner AS stock appears to be undervalued. The current stock price of €18.00 is trading 8.4% below its estimated GF Value™ of €19.65. GuruFocus considers J.Molner AS to be Fairly Valued.

Key valuation signals for OTSE:MOLNR:

  • GF Value Rank: 10 (100% above median its 10-year median of 5.00)
  • GF Value™: €19.65 vs. price of €18.00 (8.4% below fair value)
  • GF Score™: 41/100 with 7 warning signs

No single metric tells the full story. See the OTSE:MOLNR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

J.Molner AS Business Description

Address Akadeemia tee 21/5, Harju maakond, Tallinn, EST, 12618
J.Molner AS is an Estonia-based company engaged in research and development in the field of biotechnology. It is developing a portfolio of generic drug products for the United States and Canadian markets, consisting of both in-house developed medicines and acquired and in-licensed products. It operates through two complementary business units: internal generic drug development and specialized pharmaceutical services. It develops and commercializes sterile injectable, ophthalmic, and dermatology generic drugs, while also providing drug development services, analytical chemistry and stability testing. Its activities are divided into two business segments, Generic Drugs and Services, with Services generating maximum revenue. The Company generates maximum revenue from the United States.
41GF Score

Get the complete analysis for OTSE:MOLNR

GF Value Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€18.00
Price
€19.65
GF Value